The markets closed lower with the Dow falling 50 points to 17,867 as the possibility of an interest rate increase in December loomed. Nasdaq slipped 2 points to 5,142.
On the upside
BioScrip (Nasdaq: BIOS) narrowed losses for the third quarter as revenue rose.
Five9 (Nasdaq: FIVN) narrowed third quarter losses more than expected as revenue rose.
BroadSoft (Nasdaq: BSFT) reported a smaller than expected loss for the third quarter.
On the downside
Foundation Medicine (Nasdaq: FMI) widened losses more than expected even as revenue rose.
Criteo (Nasdaq: CRTO) disappointed with sharply lower third quarter earnings that fell short of expectations.
Third quarter earnings and revenue for Sucampo Pharmaceuticals (Nasdaq: SCMP) missed estimates.
In the broad market, declining issues outpaced advancers by a margin of 3 to 2 on the NYSE by nearly 10 to 9 on Nasdaq. The broader S&P 500 lost 7 points to 2,102. Bitcoin surged $41 to $428.
